CARDIOL THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
CA$1.11
-5.13%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-28.9%
3 months
-15.3%
6 months
-19.0%
1 year
+0.9%
Year to date
+16.4%
52-week range
CA$0.93 – CA$2.29
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
CA$128.6M
P/E
-5.3
P/B
7.5
P/S
—
Revenue
CA$0
Net income
-CA$34.08M
Diluted EPS
-0.34
Gross margin
—
Net margin
—
Return on equity
-180.10%
Total debt
CA$107K
Cash
CA$26.08M
Free cash flow
-CA$24.1M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | CA$0 | -CA$6.08M | — | — | -CA$4.38M |
| Mar 31, 2026 | CA$0 | -CA$10.82M | — | — | -CA$7.57M |
| Dec 31, 2025 | CA$0 | -CA$7.21M | — | — | -CA$5.23M |
| Sep 30, 2025 | CA$0 | -CA$9.96M | — | — | -CA$6.93M |
| Jun 30, 2025 | CA$0 | -CA$8.35M | — | — | -CA$4.56M |
| Mar 31, 2025 | CA$0 | -CA$8.29M | — | — | -CA$7.17M |
| Dec 31, 2024 | CA$0 | -CA$8.18M | — | — | -CA$5.6M |
| Sep 30, 2024 | CA$0 | -CA$12.73M | — | — | -CA$7.78M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent CRDL news
All market newsNo ticker-linked stories are in the current archive.